Alzheimer's disease: Newer biomarkers

Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%–80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ankit Dangi, Kaushik Chatterjee, Manjur Shah Banwa, Vinay Singh Chauhan, Prateek Yadav
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer Medknow Publications 2021
Materias:	alzheimer's disease biomarkers dementia recent advances Psychiatry RC435-571 Industrial psychology HF5548.7-5548.85
Acceso en línea:	https://doaj.org/article/13c0e70a34824c3a91cbb2d6b4eea139
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:13c0e70a34824c3a91cbb2d6b4eea139
record_format	dspace
spelling	oai:doaj.org-article:13c0e70a34824c3a91cbb2d6b4eea1392021-11-12T10:11:31ZAlzheimer's disease: Newer biomarkers0972-67480976-279510.4103/0972-6748.328840https://doaj.org/article/13c0e70a34824c3a91cbb2d6b4eea1392021-01-01T00:00:00Zhttp://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2021;volume=30;issue=3;spage=315;epage=319;aulast=Dangihttps://doaj.org/toc/0972-6748https://doaj.org/toc/0976-2795Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%–80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stands at 90%. Attempts have been made to define AD biologically. This has been made possible due to advances in the identification of biomarkers that indicate the neuropathological changes responsible for AD. Identification of these biomarkers has implications for disease staging, prognostication, and identifying drug targets. Here, we summarize the advances in the field of biomarkers in AD.Ankit DangiKaushik ChatterjeeManjur Shah BanwaVinay Singh ChauhanPrateek YadavWolters Kluwer Medknow Publicationsarticlealzheimer's diseasebiomarkersdementiarecent advancesPsychiatryRC435-571Industrial psychologyHF5548.7-5548.85ENIndustrial Psychiatry Journal, Vol 30, Iss 3, Pp 315-319 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	alzheimer's disease biomarkers dementia recent advances Psychiatry RC435-571 Industrial psychology HF5548.7-5548.85
spellingShingle	alzheimer's disease biomarkers dementia recent advances Psychiatry RC435-571 Industrial psychology HF5548.7-5548.85 Ankit Dangi Kaushik Chatterjee Manjur Shah Banwa Vinay Singh Chauhan Prateek Yadav Alzheimer's disease: Newer biomarkers
description	Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%–80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stands at 90%. Attempts have been made to define AD biologically. This has been made possible due to advances in the identification of biomarkers that indicate the neuropathological changes responsible for AD. Identification of these biomarkers has implications for disease staging, prognostication, and identifying drug targets. Here, we summarize the advances in the field of biomarkers in AD.
format	article
author	Ankit Dangi Kaushik Chatterjee Manjur Shah Banwa Vinay Singh Chauhan Prateek Yadav
author_facet	Ankit Dangi Kaushik Chatterjee Manjur Shah Banwa Vinay Singh Chauhan Prateek Yadav
author_sort	Ankit Dangi
title	Alzheimer's disease: Newer biomarkers
title_short	Alzheimer's disease: Newer biomarkers
title_full	Alzheimer's disease: Newer biomarkers
title_fullStr	Alzheimer's disease: Newer biomarkers
title_full_unstemmed	Alzheimer's disease: Newer biomarkers
title_sort	alzheimer's disease: newer biomarkers
publisher	Wolters Kluwer Medknow Publications
publishDate	2021
url	https://doaj.org/article/13c0e70a34824c3a91cbb2d6b4eea139
work_keys_str_mv	AT ankitdangi alzheimersdiseasenewerbiomarkers AT kaushikchatterjee alzheimersdiseasenewerbiomarkers AT manjurshahbanwa alzheimersdiseasenewerbiomarkers AT vinaysinghchauhan alzheimersdiseasenewerbiomarkers AT prateekyadav alzheimersdiseasenewerbiomarkers
_version_	1718430973553541120

Alzheimer's disease: Newer biomarkers

Ejemplares similares